Tag: genomics
-
New Urinary Tract Infection Diagnostic Gains Funding
A company developing a desktop system for diagnosing urinary tract infections in as little as 30 minutes is the recipient of grant funding from a public-private consortium to combat drug-resistant microbial infections.
-
Genetic Repair Company Starts-Up, Gains $87 Million
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA.
-
Crispr Deployed to Correct Inherited Vision Disorder
Researchers at Columbia University developed and tested in lab mice a technique using the genome editing technology Crispr with gene replacement therapy to correct the inherited eye disease retinitis pigmentosa.
-
University, Industry Labs Partner on Bioprinted Tissue
A joint project between Indiana University and the company Lung Biotechnology is investigating three-dimensional bioprinting to produce animal tissue for research on organ transplantation, and eventually for transplants themselves.
-
Genentech Gains Microbe Drug Discovery Tech in $1B Deal
Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil.
-
Gates Grant Funds A.I. for Malaria Drug Discovery
An award from the Bill and Melinda Gates Foundation is supporting research by a digital drug discovery company and university lab into use of artificial intelligence to find new drugs for treating malaria.
-
Digital Drug Discovery Company Wins A.I. Competition
A company using artificial intelligence algorithms and big data analytics to discover drug targets from RNA splicing errors is the winner of a competition among start-up enterprises for innovative uses of A.I. technology.
-
Cellectis, Wyss Inst. Partner on Recoding Human Genome
A bioengineering center at Harvard University and a biotechnology company are creating a process for genetically editing human cell lines to produce virus-resistant synthetic proteins for research and therapies.
-
Platform to Integrate Robotics, Synthetic Biology, A.I.
Two companies are developing a new model for a cloud-based platform that makes possible automated collaborative research with artificial intelligence in synthetic biology.
-
Gene Therapy Biotech Acquired in $8.7 Billion Deal
A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion.